{
    "q": [
        {
            "docid": "47306088_2",
            "document": "Parasitophorous vacuole . The parasitophorous vacuole (PV) is a structure produced by apicomplexan parasites in the cell of its host. The PV allows the parasite to develop while protected from the phagolysosomes of the host cell. The PV is a bubble-like compartment made of plasma membrane and containing cytoplasm and the parasite. The PV allows the parasite to exist and grow within the cell while protecting it from the host cell defense mechanisms. The PV prevents the acidification of the compartment, the mechanism by which the lysosomes of the host cell would normally destroy an invading parasite. Parasites that form a parasitophorous vacuole as part of their infection process include \"Plasmodium falciparum\", which causes malaria and \"Toxoplasma gondii\", which causes toxoplasmosis. The parasitophorous vacuole is formed during cell invasion, when the parasite uses part of the membrane of the host cell to form a parasitophorous vacuolar membrane (PVM). The PVM surrounds the intracellular parasite, creating a separate bubble of cytoplasm-filled plasma membrane within the host cell. The rhoptry and the microneme, special secretory organelles found in apicomplexan parasites, play a major role in the formation of the vacuole. One theory is that the microneme works with the rhoptry and the rhoptry secretes proteins to create the PVM, while the microneme binds to the surface of red blood cells, allowing the parasite to more easily enter into the cell.",
            "score": 104.00069499015808
        },
        {
            "docid": "2191408_24",
            "document": "Plasmodium malariae . The food vacuole is the specialized compartment that degrades hemoglobin during the asexual erythrocytic stage of the parasite. It is implied that effective drug treatments can be developed by targeting the proteolytic enzymes of the food vacuole. In a paper published in 1997, Westling \"et al.\" focused their attention on the aspartic endopeptidase class of enzymes, simply called plasmepsins. They sought to characterize the specificity for the enzymes cloned from \"P. vivax\" and \"P. malariae.\" Using substrate specificity studies and inhibitor analysis, it was found that the plasmepsins for \"P. malariae\" and \"P. vivax\" showed less specificity than that for \"P. falciparum.\" Unfortunately, this means that the development of a selective inhibitor for \"P. malariae\" may prove more challenging than the development of one for \"P. falciparum.\" Another study by Bruce \"et al.\" presented evidence that there may be regular genetic exchange within \"P. malariae\" populations. Six polymorphic genetic markers from \"P. malariae\" were isolated and analyzed in 70 samples of naturally acquired \"P. malariae\" infections from different parts of the world. The data showed a high level of multi-genotypic carriage in humans.",
            "score": 77.20158696174622
        },
        {
            "docid": "11421304_17",
            "document": "Mir-92 microRNA precursor family . The implication is that miR-92 and other miRNAs from mir-17-92 drive the formation of human MB by acting upon the SHH/PTCH pathway. In further studies with mice, an inhibitor of the SHH pathway (cyclopamine drug) was sufficient to reduce proliferation of tumour cells that had been infected with a retro virus encoding mir-17-92 (plus a GFP reporter). The level of reduction in proliferation was towards background levels of normal MB tumours: as in those uninfected with the retro virus. Once again, an aberrant SHH/PTCH pathway was necessary for these observations.",
            "score": 75.46955490112305
        },
        {
            "docid": "21898168_4",
            "document": "Leishmania mexicana . The life cycle of this and other \"Leishmania\" species begin when an infected Phlebotomine bites and injects promastigotes in the skin of the mammal host. Those promastigotes are engulfed by phagocytic cells, as macrophages and dendritic cells. The parasites are kept inside in a parasitophorous vacuole, then they will transform to amastigotes and divide until brock the cell membrane. They are released to infect new cells as amastigotes stage. When an uninfected sand fly bites an infected mammal reservoir, the sandfly ingests the amastigotes, therefore they transform in promastigotes and divide in the midgut of the fly, those promastigotes migrates to the proboscis and are able to produce Leishmaniasis disease. There are no blood stages in the life cycle of \"L. mexicana\" (unlike Malaria and Trypanosomiasis).",
            "score": 133.9288308620453
        },
        {
            "docid": "51281143_2",
            "document": "GNF6702 . GNF6702 is the name for a broad-spectrum antiprotozoal drug invented by researchers working at the Genomics Institute of the Novartis Research Foundation in 2013, with activity against leishmaniasis, Chagas disease and sleeping sickness. These three diseases are caused by related kinetoplastid parasites, which share similar biology. GNF6702 acts as allosteric proteasome inhibitor which was effective against infection with any of the three protozoal diseases in mice, while having little evident toxicity to mammalian cells.",
            "score": 76.80495357513428
        },
        {
            "docid": "57393812_21",
            "document": "HSV epigenetics . Ezh1/2 inhibitors also activate cellular antiviral pathways. Specifically, in cells treated with Ezh1/2 inhibitors, greater numbers of promyelocytic leukemia (PML) foci, which are involved with repression of gene expression, were seen, along with upregulation of interferon-alpha (IFN-\u03b1) and interleukin-8 (IL-8). These pathways are not specific to HSV; treatment with Ezh1/2 inhibitors reduced infection of multiple viral pathogens, including human cytomegalovirus, adenovirus, and Zika virus.",
            "score": 62.277079820632935
        },
        {
            "docid": "2736775_16",
            "document": "Myristoylation . Certain NMTs are therapeutic targets for development of drugs against bacterial infections. Myristoylation has been shown to be necessary for the survival of a number of disease-causing fungi including \"C. albicans\" and \"C. neoformans\". In addition to prokaryotic bacteria, the NMTs of numerous disease-causing eukaryotic organisms have been identified as drug targets as well. Proper NMT functioning in the protozoa \"Leishmania major\" and \"Leishmania donovani\" (leishmaniasis), \"Trypanosoma brucei\" (African sleeping sickness) and \"P. falciparum\" (malaria) is necessary for survival of the parasites. Inhibitors of these organisms is under current investigation. A pyrazole sulphonamide inhibitor has been identified that selectively binds \"T. brucei\", competing for the peptide binding site, thus inhibiting enzymatic activity and eliminating the parasite from the bloodstream of mice with African sleeping sickness.",
            "score": 112.70422291755676
        },
        {
            "docid": "55340810_8",
            "document": "Janus kinase 3 inhibitor . The first JAK inhibitor approved for the treatment of rheumatoid arthritis was Tofacitinib. It has also shown promising results in other autoimmune disorders. Initially, Tofacitinib was thought to be a selective JAK3 inhibitor but it later it was shown that it is also a potent inhibitor of JAK1 and JAK2. The value of developing a selective JAK3 targeting over the other JAKs is that JAK3 expression is restricted to the immune system while the other JAKs are much more broadly expressed. Since JAK3 is not as ubiquitously expressed, selective targeting could improve tolerability, and decrease possible adverse effects and safety concerns. For example dual inhibition of JAK1 and JAK3 might increase bacterial and viral infection because of a broader immunosuppressive effect. Inhibition of JAK2 has been linked to adverse effects such as anaemia and generalised leukopenia.It has been difficult to\u00a0 develop sufficiently selective JAK3 inhibitors.\u00a0One of the reason is the small variation in the ATP binding site of different JAKs. Another problem is that JAK3 has a higher affinity for ATP than the other JAKs which can be a reason for a poor translation from in vitro enzymatic assay studies to cellular system studies. An example of this is Decernotinib which showed 41-fold selectivity for JAK3 vs JAK1 in vitro enzyme assays while the selectivity for JAK3 was not maintained in cellular assays where it showed a slight preference for JAK1.",
            "score": 56.65191102027893
        },
        {
            "docid": "35602207_14",
            "document": "Parvilucifera . A characterizing difference of the P.sinerae species is the process of infection can follow two pathways depending on the host. The pathways can be identified as either cytoplasmic infection or nuclear infection. The preference of pathway is based upon whether the dinoflagellate host cell is thecate or athecate. To be thecate in dinoflagellates means to have an outer layer of cellulose plates that serves as an extra layer of protection, to be athecate means to not have this covering. If the dinoflagellate is thecate, then the pathway of infection will be nuclear; the process will follow with the de-attachment of dinoflagellate theca. If the host cell is athecate, then cytoplasmic infection will proceed which is indicated by the presence of vacuole-like structures in the cytoplasm, and because the nucleus is not infected first the dinoflagellate cell is resilient for longer than the thecate cell. Through experimental studies, for the species P.sinerae salinity may also play a significant role in terms of germabilit, as it was found that lower salinity levels would promote higher infection rates (Figueroa et al. 2008).",
            "score": 86.77340853214264
        },
        {
            "docid": "33826069_4",
            "document": "Viral neuronal tracing . The life cycle of viruses, such as those used in neuronal tracing, is different from cellular organisms. Viruses are parasitic in nature and cannot proliferate on their own. Therefore, they must infect another organism and effectively hijack cellular machinery to complete their life cycle. The first stage of the viral life cycle is called viral entry. This defines the manner in which a virus infects a new host cell. In nature, neurotropic viruses are usually transmitted through bites or scratches, as in the case of Rabies virus or certain strains of Herpesviruses. In tracing studies, this step occurs artificially, typically through the use of a syringe. The next stage of the viral life cycle is called viral replication. During this stage, the virus takes over the host cell's machinery to cause the cell to create more viral proteins and assemble more viruses. Once the cell has produced a sufficient number of viruses, the virus enters the viral shedding stage. During this stage, viruses leave the original host cell in search of a new host. In the case of neurotropic viruses, this transmission typically occurs at the synapse. Viruses can jump across the relatively short space from one neuron to the next. This trait is what makes viruses so useful in tracer studies. Once the virus enters the next cell, the cycle begins anew. The original host cell begins to degrade after the shedding stage. In tracer studies, this is the reason the timing must be tightly controlled. If the virus is allowed to spread too far, the original microcircuitry of interest is degraded and no useful information can be retrieved. Typically, viruses can infect only a small number of organisms, and even then only a specific cell type within the body. The specificity of a particular virus for a specific tissue is known as its tropism. Viruses in tracer studies are all neurotropic (capable of infecting neurons).",
            "score": 80.52450037002563
        },
        {
            "docid": "49197_31",
            "document": "Antiviral drug . HIV infects a cell through fusion with the cell membrane, which requires two different cellular molecular participants, CD4 and a chemokine receptor (differing depending on the cell type). Approaches to blocking this virus/cell fusion have shown some promise in preventing entry of the virus into a cell. At least one of these entry inhibitors\u2014a biomimetic peptide marketed under the brand name Fuzeon\u2014has received FDA approval and has been in use for some time. Potentially, one of the benefits from the use of an effective entry-blocking or entry-inhibiting agent is that it potentially may not only prevent the spread of the virus within an infected individual but also the spread from an infected to an uninfected individual.",
            "score": 63.093016624450684
        },
        {
            "docid": "772572_10",
            "document": "COX-2 inhibitor . Additional support for the idea that other targets besides COX-2 are important for celecoxib\u2019s anticancer effects has come from studies with chemically modified versions of celecoxib. Several dozen analogs of celecoxib were generated with small alterations in their chemical structures. Some of these analogs retained COX-2 inhibitory activity, whereas many others didn\u2019t. However, when the ability of all these compounds to kill tumor cells in cell culture was investigated, it turned out that the antitumor potency did not at all depend on whether or not the respective compound could inhibit COX-2, showing that inhibition of COX-2 was not required for the anticancer effects. One of these compounds, 2,5-dimethyl-celecoxib, which entirely lacks the ability to inhibit COX-2, actually turned out to display stronger anticancer activity than celecoxib itself and this anticancer effect could also be verified in highly drug-resistant tumor cells and in various animal tumor models.",
            "score": 81.68846869468689
        },
        {
            "docid": "10849236_9",
            "document": "Antibody-dependent enhancement . ADE of infection has also been reported in HIV. Like DENV, non-neutralizing level of antibodies have been found to enhance the viral infection through interactions of complement system and receptors. The increase in infection has been reported to be over 350 fold which is comparable to ADE in other viruses like DENV. ADE in HIV can be complement mediated or Fc receptor mediated. Complements in presence of HIV-1 positive sera have been found to enhance the infection of MT-2 T-cell line. The Fc-receptor mediated enhancement was reported when HIV infection was enhanced by sera from HIV-1 positive guinea pig enhanced the infection of peripheral blood mononuclear cells without the presence of any complements. Complement Component receptors CR2, CR3 and CR4 have been found to mediate this Complement \u2013Mediated enhancement of infection. The infection of HIV-1 leads to activation of complements fragments of these complements can assist viruses with infection by facilitating viral interactions with host cells that express complement receptors. The deposition of complement on the virus brings the gp120 protein close to CD4 molecules on the surface of the cells, thus leading to facilitated viral entry. Viruses pre-exposed to non-neutralizing complement system have also been found to enhance infections in interdigitating dendritic cells (iDCs). Opsonized viruses have not only shown enhanced entry but also favorable signalling cascades for HIV replication in iDCs. HIV-1 has also showed enhancement of infection in HT-29 cells when the viruses were pre-opsonized with complements C3 and C9 in seminal fluid. This enhanced rate of infection was almost 2 times greater than infection of HT-29 cells with virus alone. Subramanian \"et al.\", reported that almost 72% of serum samples out of 39 HIV positive individuals contained complements that were known to enhance the infection. They also suggested that presence of neutralizing antibody (NA) or antibody-dependent cellular cytotoxicity-mediating antibodies (ADCC) in the serum contains infection enhancing antibodies(IEAs). The balance between the NAs and IEAs changes as the disease progresses. During advanced stages of disease the proportion of IEAs are generally higher than NAs. Increase in viral protein synthesis and RNA production have been reported to occur during the complement mediated enhancement of infection. Cells that are challenged with non neutralizing levels of complements have been found have accelerated release of reverse transcriptase and the viral progeny. The interaction of anti-HIV antibodies with non-neutralizing complement exposed viruses also aid in binding of the virus and the erythrocytes which can lead to a more efficient delivery of viruses to the immune compromised organs.",
            "score": 77.25347411632538
        },
        {
            "docid": "14929103_5",
            "document": "PRO 140 . PRO 140 is a lab-made antibody that functions as an entry inhibitor. PRO 140 binds to the CCR5 receptor on the CD4 cells, and interferes with HIV's ability to enter the cell. PRO 140, a humanized form of a PA14 antibody, is a chemokine-receptor CCR5 monoclonal antibody and can inhibit CCR5 tropic HIV-1 at concentrations that do not antagonize the natural activity of CCR5 in vitro. HIV-1 entry is mediated by the HIV-1 envelope glycoproteins gp120 and gp41. The gp120 will bind CD4 and the CCR5co receptor molecule, and this triggers gp41-mediated fusion of the viral and cellular membranes. CCR5 is hence needed for the entry of the virus and this infection of healthy cells. PRO 140, the anti-CCR5 monoclonal antibody, can stop HIV from entering the cell and stop viral replication. It prevents the virus-cell binding at a distinct site in the CCR5 co-receptor without interfering with its natural activity. Unlike other entry inhibitors, PRO 140 is a monoclonal antibody. The mechanism of inhibition is competitive rather than allosteric. As such, it must be injected to be effective. However, once inside the body, PRO 140 binds to CCR5 for >60 days, which may allow for dosing as infrequently as every other week. Compared to highly-active antiretroviral therapy which has been shown to have treatment-related toxicities for HIV-infected patients, PRO140 has no multi-drug resistance or toxicities.",
            "score": 53.956608295440674
        },
        {
            "docid": "14456365_6",
            "document": "Juvenile-hormone esterase . A number of compounds have been discovered which are potent inhibitors of JH esterase. Many of these are insecticides falling into two major structural groups, the phosphoamidothiolates and S-phenylphosphates; carbamate insecticides were also tested. By far the most potent inhibitor was an ethoxythiophenylphospamidothiolate, with IC < 1 nM. Of particular interest in this study is that ethyl and isopropyl analogs of natural JHs were NOT cleaved by the esterase, showing that it is methyl ester specific. JH I and JH III were tested at nominal concentrations of 5 \u00b5M. Later a trifluoromethyl ketone (3-octylthio-1,1,1-trifluoro-2-propanone) was shown to be a highly potent, high affinity slow, tight binding inhibitor of the JH esterase of Trichoplusia ni, the same Lepidopteran which was used in the other study in this section. This study reported very sophisticated kinetic analyses of the inhibition of this compound (acronym OTFP), JH I was shown to be degraded more readily by the enzyme than JH III, with a Km value about twice the value of JH III.",
            "score": 62.566139817237854
        },
        {
            "docid": "51903_30",
            "document": "Tyrosine kinase . Cancer\u2019s response to an inhibitor of tyrosine kinase was assessed in a clinical trial. In this case, Gefitinib is the inhibitor of tyrosine kinase. Incorrect tyrosine kinase function can lead to non-small cell lung cancer. Gefitinib is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor, inducing favorable outcomes in patients with non-small cell lung cancers. A common, widespread cancer, non-small cell lung cancer is the cause of death in more people than breast, colorectal, and prostate cancer together. This is strong motivation to perform research on tyrosine kinase inhibitors as potential targets in cancer treatment. Gefitinib, functioning as an epidermal growth factor receptor tyrosine kinase inhibitor, improved symptoms related to non-small cell lung cancer and resulted in radiographic tumor regressions. This is an example of the efficacy of such an inhibitor. The process of inhibition shows how the cancer sustains. Mutations in the epidermal growth factor receptor activate signalling pathways that promote cell survival. Non-small cell lung cancer cells become dependent on these survival signals. Gefitinib\u2019s inhibition of the survival signals may be a contributing factor to its efficacy as a drug for non-small cell cancer treatment.",
            "score": 46.80124807357788
        },
        {
            "docid": "214550_18",
            "document": "Epstein\u2013Barr virus . EGCG, a polyphenol in green tea, has shown in a study to inhibit EBV spontaneous lytic infection at the DNA, gene transcription and protein levels in a time and dose-dependent manner; the expression of EBV lytic genes Zta, Rta, and early antigen complex EA-D (induced by Rta), however, the highly stable EBNA-1 gene found across all stages of EBV infection is unaffected. Specific inhibitors (to the pathways) suggest that Ras/MEK/MAPK pathway contributes to EBV lytic infection though BZLF1 and PI3-K pathway through BRLF1, the latter completely abrogating the ability of a BRLF1 adenovirus vector to induce the lytic form of EBV infection. Additionally, the activation of some genes but not others is being studied to determine just how to induce immune destruction of latently infected B-cells by use of either TPA or sodium butyrate.",
            "score": 80.63874363899231
        },
        {
            "docid": "21898168_3",
            "document": "Leishmania mexicana . \"Leishmania mexicana\" is an obligate intracellular protozoan parasite that causes the cutaneous form of leishmaniasis. This species of Leishmania is found in America. The infection with \"L. mexicana\" occurs when an individual is bitten by an infected sandfly that injects infective promastigotes, which are carried in the salivary glands and expulsed by the proboscis, directly to the skin.",
            "score": 138.17930459976196
        },
        {
            "docid": "52195015_4",
            "document": "Suvendra Nath Bhattacharyya . Bhattacharyya's researches at RBRL is mainly on microRNA (miRNA), focusing on its compartmentalization, regulation and mediation as well as its alteration in Leishmania invaded macrophage and neighboring non-macrophage cells. His researches assisted in identifying cholesterol as a modulator in leishmaniasis infection and his team has developed a therapeutic protocol for treating leishmaniasis by administering microRNA molecules in patients which has been found to raise the cholesterol level which in turn reduced the parasite levels. The treatment, combined with other drugs have been reported to be effective in treating the disease commonly known as Kala azar, which has a reported high drug resistance. One of his earlier projects, \"Mechanism of mRNA compartmentalization in the cytoplasm of mammalian cells\", was funded by the Wellcome Trust. On his current project, \"miRNA expoprt and Stability\", he has worked on the mammalian immune and cancer cells and reportedly discovered miRNA activity modulation mechanisms in those cells.",
            "score": 100.58945965766907
        },
        {
            "docid": "53918629_27",
            "document": "Evolutionary models of human drug use . For example, researchers have recently sought to understand why humans began using tobacco in spite of the consequences and adverse reactions commonly associated with its use. Hagen and colleagues propose that, as in other species, humans began using tobacco and other plant toxins as a way of controlling infection by parasitic diseases, including helminths. Tobacco, as well as arecoline and cannabis, two other plant neurotoxins that are widely used as recreational drugs in humans, have been found to be toxic to parasitic worms that affect humans and other mammals, as well as plants. Modern anthelminthics function as well by targeting nicotinic acetylcholine receptors (nAChRs) on somatic muscle cells of parasites, producing paralysis and expelling the parasite, the same receptors which are targeted by nicotine (Roulette et al., 2014). Moreover, it has also been found that nicotine is equally or more effective than commercial anthelmintics at killing leeches, including those that infect humans. Similarly, Roulette et al. (2014) found in a study comparing male smoking prevalence and parasite load among Aka hunter-gatherers that treatment with commercial anthelmintics was associated with a decrease in cotinine concentrations (a measure of current tobacco use), thereby supporting their theory that humans regulate the amount of tobacco used in response to current helminth infection. The study also found that men with higher initial tobacco use also had lower worm burdens one year later, suggesting that nicotine not only eliminates parasites, but also protects from reinfection.",
            "score": 96.84269309043884
        },
        {
            "docid": "196523_45",
            "document": "Toxoplasma gondii . Differences in sex-dependent behavior observed in infected hosts compared to non-infected individuals can be attributed to differences in testosterone. Infected males had higher levels of testosterone while infected females had significantly lower levels, compared to their non-infected equivalents. Looking at humans, studies using the Cattell\u2019s 16 Personality Factor questionnaire found that infected men scored lower on Factor G (superego strength/rule consciousness) and higher on Factor L (vigilance) while the opposite pattern was observed for infected women. This means that men were more likely to disregard rule and were more expedient, suspicious and jealous. On the other hand, women were more warm hearted, outgoing, conscientious and moralistic. Mice infected with \"T. gondii\" have a worse motor performance than non-infected mice. Thus, a computerized simple reaction test was given to both infected and non-infected adults. It was found that the infected adults performed much more poorly and lost their concentration more quickly than the control group. But, the effect of the infection only explains less than 10% of the variability in performance (i.e., there could be other confounding factors). Correlation has also been observed between seroprevalence of \"T. gondii\" in humans and increased risk of traffic accidents. Infected subjects have a 2.65 times higher risk of getting into a traffic accident. A similar study done in Turkey showed that there is a higher incidence of \"Toxoplasma gondii\" antibodies among drivers who have been involved in traffic accidents. Furthermore, this parasite has been associated with many neurological disorders such as schizophrenia. In a meta-analysis of 23 studies that met inclusion criteria, the seroprevalence of antibodies to \"T. gondii\" in people with schizophrenia is significantly higher than in control populations (OR=2.73, P<0.000001). More recent studies found that suicide attempters has significantly higher IgG antibody levels to \"T. gondii\" than patients without a suicide attempt. Infection was also shown to be associated with suicide in women over the age of 60. (P<0.005)",
            "score": 103.17344808578491
        },
        {
            "docid": "15120_7",
            "document": "Interferon . All interferons share several common effects: they are antiviral agents and they modulate functions of the immune system. Administration of Type I IFN has been shown experimentally to inhibit tumor growth in animals, but the beneficial action in human tumors has not been widely documented.  A virus-infected cell releases viral particles that can infect nearby cells. However, the infected cell can prepare neighboring cells against a potential infection by the virus by releasing interferons. In response to interferon, cells produce large amounts of an enzyme known as protein kinase R (PKR). This enzyme phosphorylates a protein known as eIF-2 in response to new viral infections; the phosphorylated eIF-2 forms an inactive complex with another protein, called eIF2B, to reduce protein synthesis within the cell. Another cellular enzyme, RNAse L\u2014also induced by interferon action\u2014destroys RNA within the cells to further reduce protein synthesis of both viral and host genes. Inhibited protein synthesis destroys both the virus and infected host cells. In addition, interferons induce production of hundreds of other proteins\u2014known collectively as interferon-stimulated genes (ISGs)\u2014that have roles in combating viruses and other actions produced by interferon. They also limit viral spread by increasing p53 activity, which kills virus-infected cells by promoting apoptosis. The effect of IFN on p53 is also linked to its protective role against certain cancers.",
            "score": 85.69375562667847
        },
        {
            "docid": "1079203_62",
            "document": "Hookworm infection . Co-infection with hookworm and \"Plasmodium falciparum\" is common in Africa. Although exact numbers are unknown, preliminary analyses estimate that as many as a quarter of African schoolchildren (17.8\u201332.1 million children aged 5\u201314 years) may be coincidentally at-risk of both \"P. falciparum\" and hookworm. While original hypotheses stated that co-infection with multiple parasites would impair the host\u2019s immune response to a single parasite and increase susceptibility to clinical disease, studies have yielded contrasting results. For example, one study in Senegal showed that the risk of clinical malaria infection was increased in helminth-infected children in comparison to helminth-free children while other studies have failed to reproduce such results, and even among laboratory mouse experiments the effect of helminths on malaria is variable. Some hypotheses and studies suggest that helminth infections may protect against cerebral malaria due to the possible modulation of pro-inflammatory and anti-inflammatory cytokines responses. Furthermore, the mechanisms underlying this supposed increased susceptibility to disease are unknown. For example, helminth infections cause potent and highly polarized immune response characterized by increased T-helper cell type 2 (T2) cytokine and Immunoglobulin E(IgE) production. However, the effect of such responses on the human immune response is unknown. Additionally, both malaria and helminth infection can cause anemia, but the effect of co-infection and possible enhancement of anemia is poorly understood.",
            "score": 108.97657108306885
        },
        {
            "docid": "14756917_2",
            "document": "Maturation inhibitor . The maturation inhibitors are a class of antiviral drugs for the treatment of infection with HIV. They act by interfering with the maturation of the virus. Specifically, drugs in this class disrupt the final step in the processing of the HIV-1 \"gag\" protein, the cleavage of its immediate precursor by the enzyme HIV-1 protease. Unlike the class of drugs known as protease inhibitors, maturation inhibitors bind the \"gag\" protein, not the protease. This leads to the formation of noninfectious, immature virus particles, incapable of infecting other cells. No other class of drugs shares this mechanism of action, thus maturation inhibitors retain inhibitory activity against HIV infections with resistance.",
            "score": 53.617480993270874
        },
        {
            "docid": "38900235_7",
            "document": "HIV/AIDS research . The within-host dynamics of HIV infection include the spread of the virus in vivo, the establishment of latency, the effects of immune response on the virus, etc. Early studies used simple models and only considered the cell-free spreading of HIV, in which virus particles bud from an infected T cell, enter the blood/extracellular fluid, and then infect another T cell. A 2015 study proposes a more realistic model of HIV dynamics that also incorporates the viral cell-to-cell spreading mechanism, where the virus is directly transited from one cell to another, as well as the T cell activation, the cellular immune response, and the immune exhaustion as the infection progresses.",
            "score": 75.24790406227112
        },
        {
            "docid": "45397365_3",
            "document": "Viral synapse . Formation of these synapses has been shown to involve reorientation of the cytoskeleton, which is triggered by engagement of ICAM-1 on the infected cell's surface and expression of several viral proteins. Viruses use the microtubule cytoskeleton to migrate to the viral synapse. By recruiting the receptors and viral particles at the point of contact, these synaptic structures significantly enhance the likelihood of a productive infection. Viral synapses are thought to explain how cell-to-cell transfer can operate in the HIV infection even when there is a low number of viral particles and a relatively low number of CD4 receptors. Recent study proposes that the fundamental \u201ckilling units\u201d of CD4 T cells leading to CD4 T-cell depletion and ultimately progression to AIDS are infected cells residing in lymphoid tissues that mediate cell-to-cell spread of the virus via virological synapses. These findings highlight a previously unappreciated role for the virological synapse in HIV pathogenesis.",
            "score": 58.5490779876709
        },
        {
            "docid": "17564957_11",
            "document": "Zinc protoporphyrin . The chemical group that ZnPP belongs to is similar to free heme which is a natural substrate of heme oxygenase. ZnPP is known as a competitive inhibitor of heme oxygenase. Heme oxygenase is a cytoprotective enzyme that copes with oxidative stress on a cell and shows higher expression in cancerous tissues. ZnPP suppression of heme oxygenase reduces cell viability of cancer cells and increases cytotoxicity in cancer cells. ZnPP works in combination with anticancer drugs to increase cytotoxicity greatly in some cases; results in one study have shown a five-fold increase in treatment efficacy. ZnPP has been shown to have a major role in inhibiting tumor growth especially solid tumors. Tumors from brain cancer, colon cancer, prostate cancer, renal cell cancer, oral squamous cell cancer, and leukemia all show a susceptibility to ZnPP due to increase expression of heme oxygenase. The inhibition of heme oxygenase leads to an increase of reactive oxidative species in the cell which sensitizes the cells to chemotherapeutic agents. Increased reactive oxidative species can cause apoptosis in cancer cells and reduce drug resistance when exposed to ZnPP due to loss of the heme oxygenase coping mechanism. The combination of these two therapies is highly effective in treating cancer in experiments thus far, and is a possible new method for overcoming drug resistance. The reduced coping ability of tissues treated with ZnPP also increases radiosensitivity. Cells treated with ZnPP and radiation as opposed to simply one of the two are less viable and more likely to stay in G1 phase of the cell cycle, rather than progress to the G2 phase. ZnPP and radiation combination therapy shows more apoptosis than the same amount of radiation displaying that ZnPP puts stress on cancerous tissue. ZnPP have been injected in a number of trials on solid tumors, but can be utilized more broadly when effectively delivered to cancer cells and not healthy cells. A targeted delivery system is need to fully exploit the uses of ZnPP as a therapeutic agent and heme oxygenase inhibitor due to the potential side effects of free ZnPP on healthy tissue. Reducing the anti-oxidant capability of healthy cells can reduce effects that would have been favorable. However ZnPP have been encapsulated in nanoparticles with specialized coating for drug delivery inside the body. ZnPP did not show any reduce inhibitory potential on heme oxygenase when loaded into nanoparticles. Similarly ZnPP loaded into nanoparticles has a higher cytotoxicity than free ZnPP after two days due to a more favorable release rate as well as better biodistribution and internalization. The possible negative effects on major organs were not seen and blood distribution is more desirable in ZnPP loaded nanoparticles than free ZnPP. The specific inhibition of heme oxygenase using nanoparticles with encapsulated ZnPP reduces side effects and is likely the future method of administering ZnPP treatment.",
            "score": 56.78635323047638
        },
        {
            "docid": "44579483_10",
            "document": "Batai virus . It is well known that the geographical distribution of Batai virus (BATV) includes the regions of Europe, Asia and Africa. The most common vertebrate affected by BATV are domestic pigs, horses, ruminants and wild birds, which have been known to be the primary mammalian hosts. The transmission cycle of BATV occurs in agricultural ecosystems via Anopheles, Culex and Ochlerotatus species mosquitoes in a typical vertebrate\u2013mosquito cycle.  While limited research has been conducted on the viral cycle of the Batai virus, comparable studies with the close relative Bunyamwera virus has shown that viral infection begins in the salivary glands of mosquitos. At the onset of replication the virus particles coalesce into vacuole membranes lining the cytoplasm of the infected cells. Entry into the cell is facilitated by the viral enveloped nucleocapsid, which contains glycoproteins G1 and G2. Encoded by the M RNA segment they are involved in attachment to the host cell through unidentified receptors on the surface and elicit neutralizing antibodies. Transcription of BATV is said to be similar to that of influenza in that mRNA synthesis is primed by cap-containing oligonucleotides that are generated by a certain viral-endonuclease, functioning to cleave the host cell mRNA. These resulting primers are then incorporated into the viral mRNA. BATV will also encode for two non-structural proteins, NSm on the M segment and NSs on the S segment. During the process it is believed that NSm actively participates in assembly of the virus. These newly assembled viral particles will mature over a period of time inside of the hosts cell in the membranes of the Golgi apparatus before being released. However, while able to replicate in both vertebrate and invertebrate species, in mosquito cells no cell death is observed and persistent infection is established. Whereas in mammalian cells infection is typically categorized as lytic and eventually leads to cell death. This stems from the viruses ability to form clear lytic plaques in cells of vertebrate species but not in those derived from insects. It has been demonstrated in previous studies that in mammalian cells, the NSs protein will induce a shut-off of host protein synthesis which will lead to the death of the host cell. It has also been shown to counteract the host cell antiviral response. This would establish it as the main virulence factor as it acts during the transcriptional phase by inhibiting RNA polymerase II\u2013mediated transcription. Meanwhile, the mosquito cells neither host cell transcription nor translation are inhibited by this fact. It would seem the difference in the behavior of the NSs protein could be one of the factors responsible for the different outcomes of infection attributed to the Batai virus in mammalian and mosquito cells. Some have theorized that a release method that does not rupture the cell membrane could explain why viral replication does not kill mosquito cells and persistence is maintained. Similar NSs proteins of the Rift Valley fever phlebovirus have quite a distinct size and amino acid sequence, but they play a similar role in mammalian cells in overcoming the innate immune responses that are a consequence of the global shut-down of the cells transcription mechanisms. Similar NSs proteins of the Rift Valley fever phlebovirus have quite a distinct size and amino acid sequence, but they play a similar role in mammalian cells in overcoming the innate immune responses that are a consequence of the global shut-down of the cells transcription mechanisms.",
            "score": 76.69041669368744
        },
        {
            "docid": "5460467_6",
            "document": "Xenoma . Xenomas are provoked in various types of organisms, depending on the species of the parasite. Microsporidia are known to produce xenomas in oligochaetes, insects, crustaceans and fish. In addition to organism specificity, different species of parasite will have distinct host cell specificity, even if targeting the same organism. For example, \"Microsporidium chaetogastris\" infects solely connective and muscle tissue cells of the annelid \"Chaetogaster diaphanus\", whereas other species of microsporidia will target other tissue types. Another example is microsporidial gill disease in different species of fish caused by \"Loma salmonae\". It was found that certain species had a higher prevalence of xenoma formation following infection with the same parasite i.e. xenomas per gill filament in chinook salmon was 8 to 33 times greater than in rainbow trout, showing differences in host cell susceptibility. Once a host cell is infected with the microsporidian (or protist) parasite, a complete restructuring of the host cell ensues. This occurs as the parasite seeks to take control of the metabolism of the cell, in order to survive and exploit the host cell's resources and reproduction. It provides the parasite with optimal growth conditions and protection from the host's immune response. The parasite proliferates within the host cell where its mass replaces most of the host cell's cytoplasm, with the rest being taken up by microvillus structures and rhizoids. Other structures may be present inside the infected host cell including vesicles, fat globules and bundles of fibril. The nucleus may be in varying locations including the centre of the cell and may also vary in structure i.e. lobed, branched or divided into multiple fragments, but it will always be hypertrophic. The host also commonly envelops the proliferating parasite and the host cell itself in layers of membranes and cells.",
            "score": 105.57022190093994
        },
        {
            "docid": "35949206_11",
            "document": "Pathophysiology of HIV/AIDS . Recent studies employed an ex vivo human lymphoid aggregate culture (HLAC) system formed with fresh human tonsil or spleen tissue to model molecular and cellular events in human tissues during in vivo HIV infection. These studies found that >95% of CD4 T cells die because of abortive HIV infection. These dying cells are resting and thus are nonpermissive for productive HIV infection. Full viral replication was limited to the \u223c5% of activated CD4 T cells present in these tissues; these cells die by apoptosis. Abortive HIV infection occurs due to slowing of reverse transcription promoting cytosolic DNA accumulation. This viral DNA is sensed by gamma-interferon-inducible protein 16 (IFI16), which produces an innate immune response against the virus by activating caspase 1 in IFI16 inflammasomes and inducing pyroptosis, a highly inflammatory form of programmed cell death. These findings cast CD4 T-cell death during HIV infection in a different light. Rather than the virus playing a major role, it is the host response to viral DNA produced during abortive infection that triggers CD4 T-cell death. Further, these findings identify novel drug targets that may be exploited to both block CD4 T cell demise and the chronic inflammatory response generated during pyroptosis.",
            "score": 75.76181554794312
        },
        {
            "docid": "48748497_3",
            "document": "PD-1 and PD-L1 inhibitors . PD-1 and PD-L1 inhibitors act to inhibit the association of the programmed death-ligand 1 (PD-L1) with its receptor, programmed cell death protein 1 (PD-1). The interaction of these cell surface proteins is involved in the suppression of the immune system and occurs following infection to limit the killing of bystander host cells and prevent autoimmune disease. This immune checkpoint is also active in pregnancy, following tissue allografts, and in different types of cancer. The concept of blocking PD-1 and PD-L1 for the treatment of cancer was first published in 2001. Pharmaceutical companies began attempting to develop drugs to block these molecules, and the first clinical trial was launched in 2006, evaluating nivolumab. As of 2017, more than 500 clinical trials involving PD-1 and PD-L1 inhibitors have been conducted in more than 20,000 patients.",
            "score": 58.908730268478394
        },
        {
            "docid": "25327696_19",
            "document": "Acid-sensing ion channel . Amiloride is an example of an ASIC inhibitor, while not considered highly potent due to an IC50 value in the micromolar range, has allowed for studies on ASIC inhibition effects on migraines. During a migraine, cortical spreading depression is observed which causes ion imbalances and the release of charged molecules which may activate ASIC. Testing of amiloride in rodents, showed a decrease in the cortical spreading depression during a migraine. Studies showed that amiloride acts as a competitive inhibitor of the ASIC chapters. The use of amiloride also showed side effects in rodents due to inhibition of sodium/ calcium exchangers. The inhibition of these exchangers disrupts cellular calcium homeostasis and causes high levels of calcium in the cell which explains the reduced neuroprotective efficacy with the use of amiloride. The findings that have come through due to ASIC inhibition by amiloride are promising and support the therapeutic potential. However, due to amiloride's lack of specificity and potency, further drug development on its structure will need to be done before a drug can be released.",
            "score": 52.71419084072113
        }
    ],
    "r": [
        {
            "docid": "50468_28",
            "document": "Leishmania . Lipophosphoglycan is used by the parasite to promote its survival in the host and the mechanisms by which the parasite does this center around modulating the immune response of the host. This is vital, as the \"Leishmania\" parasites live within macrophages and need to prevent the macrophages from killing them. Lipophosphoglycan has a role in resisting the complement system, inhibiting the oxidative burst response, inducing an inflammation response and preventing natural killer T cells recognising that the macrophage is infected with the \"Leishmania\" parasite.",
            "score": 149.84161376953125
        },
        {
            "docid": "21898168_3",
            "document": "Leishmania mexicana . \"Leishmania mexicana\" is an obligate intracellular protozoan parasite that causes the cutaneous form of leishmaniasis. This species of Leishmania is found in America. The infection with \"L. mexicana\" occurs when an individual is bitten by an infected sandfly that injects infective promastigotes, which are carried in the salivary glands and expulsed by the proboscis, directly to the skin.",
            "score": 138.17930603027344
        },
        {
            "docid": "21898168_4",
            "document": "Leishmania mexicana . The life cycle of this and other \"Leishmania\" species begin when an infected Phlebotomine bites and injects promastigotes in the skin of the mammal host. Those promastigotes are engulfed by phagocytic cells, as macrophages and dendritic cells. The parasites are kept inside in a parasitophorous vacuole, then they will transform to amastigotes and divide until brock the cell membrane. They are released to infect new cells as amastigotes stage. When an uninfected sand fly bites an infected mammal reservoir, the sandfly ingests the amastigotes, therefore they transform in promastigotes and divide in the midgut of the fly, those promastigotes migrates to the proboscis and are able to produce Leishmaniasis disease. There are no blood stages in the life cycle of \"L. mexicana\" (unlike Malaria and Trypanosomiasis).",
            "score": 133.9288330078125
        },
        {
            "docid": "20763865_2",
            "document": "Leishmania donovani . Leishmania donovani is a species of intracellular parasites belonging to the genus \"Leishmania\", a group of haemoflagellate kinetoplastids that cause the disease leishmaniasis. It is a human blood parasite responsible for visceral leishmaniasis or \"kala-azar\", the most severe form of leishmaniasis. It infects the mononuclear phagocyte system including spleen, liver and bone marrow. Infection is transmitted by species of sandfly belonging to the genus \"Phlebotomus\" in Old World and \"Lutzomyia\" in New World. Therefore, the parasite is prevalent throughout tropical and temperate regions including Africa (mostly in Sudan), China, India, Nepal, southern Europe, Russia and South America. It is responsible for thousands of deaths every year and has spread to 88 countries, with 350 million people at constant risk of infection and 0.5 million new cases in a year.",
            "score": 133.50442504882812
        },
        {
            "docid": "50468_32",
            "document": "Leishmania . Upon microbial infection, PMNs move out from the bloodstream through the vessels\u2019 endothelial layer, to the site of the infected tissue (dermal tissue after fly bite). They immediately initiate the first immune response and phagocytize the invader by recognition of foreign and activating surfaces on the parasite. Activated PMN secrete chemokines, IL-8 particularly, to attract further granulocytes and stimulate phagocytosis. Further, \"L. major\" increases the secretion of IL-8 by PMNs. This mechanism is observed during infection with other obligate intracellular parasites, as well. For microbes like these, multiple intracellular survival mechanisms exist. Surprisingly, the coinjection of apoptotic and viable pathogens causes by far a more fulminate course of disease than injection of only viable parasites. When the anti-inflammatory signal phosphatidylserine usually found on apoptotic cells, is exposed on the surface of dead parasites, \"L. major\" switches off the oxidative burst, thereby preventing killing and degradation of the viable pathogen.",
            "score": 131.60202026367188
        },
        {
            "docid": "198491_6",
            "document": "Leishmaniasis . Leishmaniasis is transmitted by the bite of infected female phlebotomine sandflies which can transmit the protozoa \"Leishmania\". The sandflies inject the infective stage, metacyclic promastigotes, during blood meals (1). Metacyclic promastigotes that reach the puncture wound are phagocytized by macrophages (2) and transform into amastigotes (3). Amastigotes multiply in infected cells and affect different tissues, depending in part on which \"Leishmania\" species is involved (4). These differing tissue specificities cause the differing clinical manifestations of the various forms of leishmaniasis. Sandflies become infected during blood meals on infected hosts when they ingest macrophages infected with amastigotes (5,6). In the sandfly's midgut, the parasites differentiate into promastigotes (7), which multiply, differentiate into metacyclic promastigotes, and migrate to the proboscis (8).",
            "score": 128.24359130859375
        },
        {
            "docid": "50468_34",
            "document": "Leishmania . The lifespan of neutrophil granulocytes is quite short. They circulate in bloodstream for about 6 to 10 hours after leaving bone marrow, whereupon they undergo spontaneous apoptosis. Microbial pathogens have been reported to influence cellular apoptosis by different strategies. Obviously because of the inhibition of caspase3-activation, \"L. major\" can induce the delay of neutrophils apoptosis and extend their lifespan for at least 2\u20133 days. The fact of extended lifespan is very beneficial for the development of infection because the final host cells for these parasites are macrophages, which normally migrate to the sites of infection within two or three days. The pathogens are not dronish; instead they take over the command at the primary site of infection. They induce the production by PMNs of the chemokines MIP-1\u03b1 and MIP-1\u03b2 (macrophage inflammatory protein) to recruit macrophages.",
            "score": 124.97315979003906
        },
        {
            "docid": "1171686_14",
            "document": "Regulatory T cell . Studies of human subjects with a history of leishmania infection suggest that modulation of CD8 suppressor T cells is, at least partly, mediated by cytokines. Leishmania specific CD4 helper T cells predominate in adults with strong protective immunity (skin-test positive with no history of clinical infection). When added to autologous leishmania infected macrophages these T cells cause parasite death and secretion of large amounts of interferon-gamma and lymphotoxin. CD8 T suppressor cells predominate in patients with no protective immunity (visceral leishmaniasis patients). When added to autologous peripheral blood mononuclear cells isolated after successful treatment, these T cells inhibit interferon-gamma secretion and proliferation and increase interleukin-6 and interleukin-10 secretion. A soluble factor(s) generated by antigen or phytohemagglutinin stimulation of leishmania-specific CD4 helper T cells from skin-test positive adults killed CD8 T cells but not CD4 helper T cells when added to culture media. Soluble factors generated by antigen stimulation of peripheral blood mononuclear cells from skin-test positive adults prevented CD8 suppressor T cell mediated increases in interleukin-10 secretion. These findings suggest that antigen stimulation of CD4 helper T cells results in production of cytokines that kill or down regulate CD8 T suppressor cells. Once the leishmania infection has been eliminated and leishmania antigens are gone, CD8 T suppressor cells down-regulate CD4 T helper cells. Isolation of cytokines that inhibit and kill CD8 T suppressor cells might be useful in treating diseases that involve immune suppression such as leishmaniasis, AIDS, and certain cancers.",
            "score": 123.35213470458984
        },
        {
            "docid": "12874039_4",
            "document": "Alan Fairlamb . In 1985, Alan Fairlamb discovered a unique thiol compound present in these parasites, and named it trypanothione. This thiol metabolite is quite different from its human equivalent, glutathione. Trypanothione allows the parasites to fend off free radicals and other toxic oxidants produced by the immune system of the infected patient, and was shown to be vital for parasite survival and virulence. For instance, antimonials neutralize the Leishmania parasite\u2019s antioxidant defence system, allowing the patient to clear the infection. Studies on the effect of drugs on trypanothione metabolism resulted in the discovery that fexinidzole is a potential oral treatment for visceral leishmaniasis.",
            "score": 123.05746459960938
        },
        {
            "docid": "73592_15",
            "document": "Toxoplasmosis . It should be noted that since the parasite can change the host's immune response, it may also have an effect, positive or negative, on the immune response to other pathogenic threats. This includes, but is not limited to, the responses to infections by \"Helicobacter felis\", \"Leishmania major\", or other parasites, such as \"Nippostrongylus brasiliensis\".",
            "score": 121.75676727294922
        },
        {
            "docid": "2930584_7",
            "document": "Visceral leishmaniasis . Response to infection by \"Leishmania donovani\" varies a great deal, not only by the strength but also by the type of the patient's immune reaction. People with a history of infection by strains of leishmania that cause visceral leishmaniasis show a continuum of immune responses from protective to non-protective. Those who acquired protective immunity (skin test positive) without ever having visceral leishmaniasis have a strong type 1 CD4+ response to leishmania antigens. Antigen specific interferon-gamma and proliferation, as well as the ability to kill intracellular leishmania, are hallmarks of protective immunity. Because visceral leishmaniasis patients lack these responses to leishmania and other antigens, they usually die of secondary infections if left untreated. In addition, increased interleukin-10 secretion is characteristic of the disease. Addition of interleukin-12, anti-interleukin-10, or anti-interleukin-4 to peripheral blood mononuclear cells from acute patients sometimes increases interferon-gamma secretion and proliferation. Acute patient peripheral blood mononuclear cells include CD8+ T regulatory cells that decrease interferon-gamma secretion and proliferation responses to leishmania and other antigens and increase interleukin-10 secretion when added to autologous peripheral blood mononuclear cells harvested after successful treatment. Thus, the CD8+ T regulatory cells reproduce the immune response characteristic of visceral leishmaniasis. CD8+ T regulatory cells are also associated with post kala azar dermal leishmaniasis. Addition of interleukin-12 or interferon-gamma does not prevent CD8+ T regulatory activity. The dominance of type 1 CD4+ T cells in skin test positive adults maybe explained by their secretion of factors that inhibit and kill CD8+ T regulatory cells. Successfully treated patients rarely develop visceral leishmaniasis a second time. Their peripheral blood mononuclear cells show a mixed T1/T2 CD4+ and CD8+ T suppressor response but do have the ability to kill intracellular leishmania.",
            "score": 120.80781555175781
        },
        {
            "docid": "198491_2",
            "document": "Leishmaniasis . Leishmaniasis is a disease caused by parasites of the \"Leishmania\" type. It is spread by the bite of certain types of sandflies. The disease can present in three main ways: cutaneous, mucocutaneous, or visceral leishmaniasis. The cutaneous form presents with skin ulcers, while the mucocutaneous form presents with ulcers of the skin, mouth, and nose, and the visceral form starts with skin ulcers and then later presents with fever, low red blood cells, and enlarged spleen and liver. Infections in humans are caused by more than 20 species of \"Leishmania\". Risk factors include poverty, malnutrition, deforestation, and urbanization. All three types can be diagnosed by seeing the parasites under the microscope. Additionally, visceral disease can be diagnosed by blood tests. Leishmaniasis can be partly prevented by sleeping under nets treated with insecticide. Other measures include spraying insecticides to kill sandflies and treating people with the disease early to prevent further spread. The treatment needed is determined by where the disease is acquired, the species of \"Leishmania\", and the type of infection. Some possible medications used for visceral disease include liposomal amphotericin B, a combination of pentavalent antimonials and paromomycin, and miltefosine. For cutaneous disease, paromomycin, fluconazole, or pentamidine may be effective. About 4 to 12 million people are currently infected in some 98 countries. About 2 million new cases and between 20 and 50 thousand deaths occur each year. About 200\u00a0million people in Asia, Africa, South and Central America, and southern Europe live in areas where the disease is common. The World Health Organization has obtained discounts on some medications to treat the disease. It is classified as a neglected tropical disease. The disease may occur in a number of other animals, including dogs and rodents.",
            "score": 120.60688781738281
        },
        {
            "docid": "2189559_10",
            "document": "Lutzomyia . The New World \"Leishmania\" species transmitted by \"Lutzomyia\" sand flies are often classified in the subgenus, \"Viannia\". These genetically distinct parasites show markedly different patterns of development within the New World sand flies when compared to those seen in the Old World \"Phlebotomus\" sand flies. The first stages of development are similar between all \"Leishmania\" species, with the sandfly taking up the amastigote form of the parasite following a bite of an infected host. However, unlike in the Old World, the replicated parasites then migrate to the hindgut of the \"Lutzomyia\" sand fly, a feature which is thought to be essential in allowing the parasite to become established. The parasite then undergoes further development into the infective, promastigote stage as it migrates to anterior end of the insect, ready for inoculation into a new, susceptible host.",
            "score": 120.12134552001953
        },
        {
            "docid": "57323017_5",
            "document": "Chandrima Shaha . Shaha's research programme is geared towards the understanding of cell death pathways and cellular defense processes in unicellular and multicellular organisms that have important bearing on designing of therapies for various diseases. Kala-azar, a neglected tropical disease remains a huge problem being endemic in certain parts of the country and is caused by the \"Leishmania\" parasite. Understanding of how parasite death occurs is important as successful killing of the parasite would reduce disease burden. The research demonstrated the ability of the \"Leishmania\" parasite to execute death phenotypes similar to metazoans and experimental evidence demonstrated the involvement of the single mitochondrion in apoptosis like death in one of the earliest eukaryotes. Host-parasite interaction studies show the involvement of Bcl-2 proteins in parasite survival. Other studies with cells having high division index like cancer cells and mammalian germ cells provides insight into the various pathways that are triggered by stress and their functional relevance in cell survival.",
            "score": 119.79696655273438
        },
        {
            "docid": "50468_3",
            "document": "Leishmania . The first written reference to the conspicuous symptoms of cutaneous leishmaniasis surfaced in the Paleotropics within oriental texts dating back to the 7th century BC (allegedly transcribed from sources several hundred years older, between 1500 and 2000 BC). Due to its broad and persistent prevalence throughout antiquity as a mysterious disease of diverse symptomatic outcomes, leishmaniasis has been dubbed with various names ranging from \"white leprosy\" to \"black fever\". Some of these names suggest links to negative cultural beliefs or mythology, which still feed into the social stigmatization of leishmaniasis today. Members of an ancient genus of the \"Leishmania\" parasite, Paleoleishmania, have been detected in fossilized sand flies dating back to the early Cretaceous period, however, the causative agent for the disease was only discovered in 1901 as a concurrent finding by William Boog Leishman and Charles Donovan. They independently visualised microscopic single-celled parasites (later called Leishman-Donovan bodies) living within the cells of infected human organs. The parasitic genus would later be classed as Trypanosomatid protozoans under the phylogenetic designation, \"Leishmania donovani\". Several species have since been classified and grouped under two major subgenera i.e. \"Leishmania Viannia\" (generally located in the Neotropics) or \"Leishmania Leishmania\" (generally located in the Paleotropics, with the major exception of the \"L. mexicana\" subgroup).",
            "score": 118.09884643554688
        },
        {
            "docid": "12738869_2",
            "document": "Leishmania major . Leishmania major is a species of parasites found in the genus \"Leishmania\", and is associated with the disease zoonotic cutaneous leishmaniasis (also known as Aleppo boil, Baghdad boil, Bay sore, Biskra button, Chiclero ulcer, Delhi boil, Kandahar sore, Lahore sore, Oriental sore, Pian bois, and Uta). \"L. major\" is an intracellular pathogen which infects the macrophages and dendritic cells of the immune system. Though \"Leishmania\" species are found on every continent aside from Antarctica, \"Leishmania major\" is found only in the Eastern Hemisphere, specifically in Northern Africa, the Middle East, Northwestern China, and Northwestern India.",
            "score": 116.5492172241211
        },
        {
            "docid": "20929959_2",
            "document": "Leishmania tropica . Leishmania tropica is a species of flagellate parasites that infects humans and hyraxes, and the cause of the disease Leishmaniasis Recidivans, a form of cutaneous leishmaniasis. L. tropica infection results in non-ulcerating disease.<Korean J Parasitol. 2007 Jun;45(2):103-9.> <Mahmoudzadeh-Niknam H1, Kiaei SS, Iravani D.>",
            "score": 115.36660766601562
        },
        {
            "docid": "21898160_6",
            "document": "Leishmania braziliensis . \"Leishmania braziliensis\", like other species of Leishmania rely on asexual reproduction in the intermediate mammalian host to greatly increase population density. Such reproduction is often witnessed in mononuclear phagocytes (dendritic cells, monocytes, neutrophils) of the mammalian host, with the macrophages being the target white blood cell of the parasite. Recently, it has been hypothesized through two studies that certain members of Leishmania genus (e.g. \"L. braziliensis\") are capable of sexual reproduction in the gut of the sand-fly vector. More work is needed to establish a clear pattern of sexual reproduction in the genus.",
            "score": 114.1033935546875
        },
        {
            "docid": "443416_44",
            "document": "Phagocyte . Some survival strategies often involve disrupting cytokines and other methods of cell signaling to prevent the phagocyte's responding to invasion. The protozoan parasites \"Toxoplasma gondii\", \"Trypanosoma cruzi\", and \"Leishmania\" infect macrophages, and each has a unique way of taming them. Some species of \"Leishmania\" alter the infected macrophage's signalling, repress the production of cytokines and microbicidal molecules\u2014nitric oxide and reactive oxygen species\u2014and compromise antigen presentation.",
            "score": 113.8405532836914
        },
        {
            "docid": "8129870_19",
            "document": "Alveolar macrophage . IL-10 inhibits the secretion of pro-inflammatory cytokines TNF-alpha and INF-gamma, thus suppressing the proliferation of T-cells, NK cells, and AM. IL-10 shares similar immunomodulating mechanisms to TGF-\u03b2. It is thought that both cytokines reduce the rate of apoptosis in human alveolar macrophages, thus indirectly enhancing alveolar macrophage-mediated inhibition of T-cell proliferation. There is a significant increase in the basal rate of apoptosis upon activation by bacterial products. Apoptosis is particularly regulated by the presence of cytokines: IFN-\u03b3 increases the rate of apoptosis, whereas IL-10 and TGF-\u03b2 decrease it. However, IL-10 has counterproductive effects on the immune system, and has been shown to actually promote infection by foreign pathogens. The role of IL-10 in bacterial and parasitic infection has been discovered as a strategy to evade host immune systems. There are bacteria which parasitize AMs by invading through their membranes, and thrive by growing and replicating inside of them, exploiting AMs as host cells. Normally, this infection can be eliminated by T-cells, which activate enzymes in alveolar macrophages that destroy the bacteria; but these bacteria have been shown to alter the cytokine signaling network to their advantage. As an inhibitory cytokine, IL-10 facilitates the infection of human alveolar macrophages and monocytes by completely reversing the protective effect of IFN-\u03b3 against intracellular Legionella pneumophila replication. Yersinia enterocolitica has also been shown to releases virulence antigen LcrV, which induces IL-10 through Toll-like receptor-2 and CD14 (an accessory surface protein of TLR4-mediated LPS-signaling), resulting in the suppression of IFN-\u03b3 and TNF-alpha suppression.",
            "score": 113.61894989013672
        },
        {
            "docid": "12541741_30",
            "document": "Yellow-spotted rock hyrax . The bush hyrax is likely a reservoir for \"Leishmania aethiopica\". One study captured 48 hyraxes from various colonies from 3 different locations in Ethiopia. Of these, three were infected with \"Leishmania aethiopia\". However, there were no visible lesions and no amastogote stage parasites present, thus indicating that the bush hyrax is a reservoir and not a suitable host. The vector of \"Leishmania aethiopica\" is \"Phlebotomus longipes\".",
            "score": 113.10102844238281
        },
        {
            "docid": "2736775_16",
            "document": "Myristoylation . Certain NMTs are therapeutic targets for development of drugs against bacterial infections. Myristoylation has been shown to be necessary for the survival of a number of disease-causing fungi including \"C. albicans\" and \"C. neoformans\". In addition to prokaryotic bacteria, the NMTs of numerous disease-causing eukaryotic organisms have been identified as drug targets as well. Proper NMT functioning in the protozoa \"Leishmania major\" and \"Leishmania donovani\" (leishmaniasis), \"Trypanosoma brucei\" (African sleeping sickness) and \"P. falciparum\" (malaria) is necessary for survival of the parasites. Inhibitors of these organisms is under current investigation. A pyrazole sulphonamide inhibitor has been identified that selectively binds \"T. brucei\", competing for the peptide binding site, thus inhibiting enzymatic activity and eliminating the parasite from the bloodstream of mice with African sleeping sickness.",
            "score": 112.7042236328125
        },
        {
            "docid": "12175069_12",
            "document": "Big-eared climbing rat . The big-eared climbing rat has been a subject of study due to a disease caused by Leishmania (L.) Mexicana. This is an intracellular parasite that infects these rodents and makes them a good model choice for further research on this topic.",
            "score": 112.54305267333984
        },
        {
            "docid": "1171686_12",
            "document": "Regulatory T cell . An important question in the field of immunology is how the immunosuppressive activity of regulatory T cells is modulated during the course of an ongoing immune response. While the immunosuppressive function of regulatory T cells prevents the development of autoimmune disease, it is not desirable during immune responses to infectious microorganisms. Current hypotheses suggest that, upon encounter with infectious microorganisms, the activity of regulatory T cells may be downregulated, either directly or indirectly, by other cells to facilitate elimination of the infection. Experimental evidence from mouse models suggests that some pathogens may have evolved to manipulate regulatory T cells to immunosuppress the host and so potentiate their own survival. For example, regulatory T cell activity has been reported to increase in several infectious contexts, such as retroviral infections (the most well-known of which is HIV), mycobacterial infections (like tuberculosis), and various parasitic infections including \"Leishmania\" and malaria.",
            "score": 112.53919219970703
        },
        {
            "docid": "50468_13",
            "document": "Leishmania . \"Endotrypanum\" is also closely related and may also be moved to subgenus status within \"Leishmania\". The subgenus \"Endotypanum\" is unique in that the parasites of this subgenus infect the erythrocytes of their hosts (sloths). The species in this subgenus are confined to Central and South America.",
            "score": 112.40865325927734
        },
        {
            "docid": "53827607_2",
            "document": "Leishmania amazonensis . Leishmania amazonesis is a parasite responsible for the disease leishmaniasis. This species has been known to spread by using sandflies as its vector and a vertebrate as its primary host, just like other species of Leishmania. They have also been known to spread throughout the Brazilian Amazon region due to their ecological niches needed for survival and reproduction. However, when the host is infected, the Leishmania can cause 3 different forms of Leishmaniasis. For this species, it has been known to cause cutaneous leishmaniasis and mucocutaneous leishmaniasis. Cutaneous leishmaniasis is commonly characterized with skin lesions, which can appear localized, or throughout the body. While mucocutaneous leishmaniasis is characterized with ulcers around the skin, mouth, and nose. This form of Leishmaniasis has also been known to can spread by metastasis and can be deadly.",
            "score": 111.9134521484375
        },
        {
            "docid": "2189657_3",
            "document": "Phlebotomus . In the Old World, \"Phlebotomus\" sand flies are primarily responsible for the transmission of leishmaniasis, an important parasitic disease, while transmission in the New World, is generally via sand flies of the genus \"Lutzomyia\". The protozoan parasite itself is a species of the genus \"Leishmania\". Leishmaniasis normally finds a mammalian reservoir in rodents and other small animals such as canids (canine leishmaniasis) and hyraxes. The female sand fly carries the \"Leishmania\" protozoa from infected animals after feeding, thus transmitting the disease, while the male feeds on plant nectar.",
            "score": 111.43311309814453
        },
        {
            "docid": "12591953_5",
            "document": "Crithidia fasciculata . \"C. fasciculata\" is an example of a non-human infective trypanosomatid and is related to several human parasites, including \"Trypanosoma brucei\" (which causes African trypanosomiasis) and \"Leishmania\" spp. (which cause Leishmaniasis). \"C. fasciculata\" parasitizes several species of insects and has been widely used to test new therapeutic strategies against parasitic infections. \"C. fasciculata\" is often used as a model organism in research into trypanosomatid biology that may then be applied to understanding the biology of the human infective species.",
            "score": 110.86044311523438
        },
        {
            "docid": "53631421_14",
            "document": "Parasitic flies of domestic animals . Species of \"Phlebotomus\" and \"Lutzomyia\" sandflies are notorious as transmitters of species of \"Leishmania\" protozoa that cause visceral and cutaneous leishmaniasis in domestic animals and also humans. Dogs become infected with \"Leishmania infantum\" and \"L.tropica\"; the infection can slowly develop into a multi-organ stage with fatal consequences.  The typical genus is \"Simulium\", but also \"Cnephia\" and \"Austrosimulium\" are locally important.",
            "score": 110.61395263671875
        },
        {
            "docid": "50468_30",
            "document": "Leishmania . Usually, a phagocytotic immune cell like a macrophage will ingest a pathogen within an enclosed endosome and then fill this endosome with enzymes which digest the pathogen. However, in the case of \"Leishmania\", these enzymes have no effect, allowing the parasite to multiply rapidly. This uninhibited growth of parasites eventually overwhelms the host macrophage or other immune cell, causing it to die.",
            "score": 110.17630767822266
        },
        {
            "docid": "12738869_4",
            "document": "Leishmania major . Upon entering the mammalian bloodstream, \"L. major\" meets the focal point of infection, the macrophage. As a result of two surface molecules, the protease gp63 and a lipophosphoglycan, promastigotes are able to bind to several macrophage receptors. Promastigote attachment to macrophages is facilitated by a number of receptors, including complement receptors CR1 and CR3, and the receptor for advanced glycosylation end products. Activation of complements occurs far from the cell membrane, and insertion of the membrane attack complex does not occur. This action is what allows the parasite to avoid being lysed, and to persist within the host's macrophages.",
            "score": 109.51201629638672
        },
        {
            "docid": "3340565_5",
            "document": "Heligmosomoides polygyrus . Upon infection with \"H. polygyrus\", innate and adaptive host immune responses are generated to prevent the establishment of the parasite in the gut. A strong wound healing immune response (Th2-type) associated with intestinal pathology is mounted. Similar to other roundworm infections Th2 immunity focuses on eliminating the parasite or confining it to minimize host damage.Mucus secreted by goblet cells of the intestine, acts as the first line of defense, hence increases in goblet cell number are a major observable change during \"H. polygyrus\" infection. Macrophages are activated through Th2 cytokines and they are important in parasite clearance by increase intestinal motility and to induce fibrosis and healing. These immune cells are also important in granuloma formation. This is a defensive response by the host to trap the parasite and minimize its damage to the gut. In addition, these cells are important in increasing contractions of the gut wall, which facilitates worm expulsion. The spleen, mesenteric lymph nodes, Peyer\u2019s patches and lamina propria lymphocytes induce a strong Th2 immune response by producing different cytokines (Interleukin 3, IL4, IL5, IL9, IL10 and IL13) which are important in controlling and expelling worms. These cytokines aid in generating CD4 T helper 2 effector cells necessary for adaptive immune responses against the parasite. In addition costimulatory signals via CD80 and CD86 has also be shown important in mounting a Th2 immune response and producing immunoglobulin E (IgE). In the humoral arm of immunity, parasite specific IgG1 plays a greater role in protection during infection and IgA has been shown to have a minor effect. But IgM and IgE has not been shown important against \"H. polygyrus\" protection.",
            "score": 109.00829315185547
        }
    ]
}